Recent Developments in the Pharmacological Reduction of Blood Glucose in Patients With Type 2 Diabetes
Open Access
- 1 October 2001
- journal article
- Published by American Diabetes Association in Clinical Diabetes
- Vol. 19 (4) , 153-159
- https://doi.org/10.2337/diaclin.19.4.153
Abstract
IN BRIEF The pharmacological management of type 2 diabetes has changed dramatically in the past few years with the introduction of many new medications, including α-glucosidase inhibitors, a biguanide, the thiazolidinediones, insulin analogs, meglitinides, and d-phenylalanine derivatives. These new agents have dramatically increased the number of options available to providers and patients. Combination therapy has become commonplace for the management of hyperglycemia in patients with type 2 diabetes. This article briefly reviews some of the more recent pharmacological advances in diabetes care.Keywords
This publication has 11 references indexed in Scilit:
- Basal Insulin Therapy in Type 2 DiabetesDiabetes Care, 2001
- Mealtime Glucose Regulation With Nateglinide in Healthy VolunteersDiabetes Care, 2001
- Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.Diabetes Care, 2000
- Insulin aspart vs. human insulin in the management of long‐term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trialDiabetic Medicine, 2000
- Nateglinide, but not glyburide, selectively enhances early insulin release and more effectively controls post-meal glucose excursions with less total insulin exposureDiabetes Research and Clinical Practice, 2000
- Long-term treatment of type 2 diabetes mellitus with glimepiride is weight neutral: A meta-analysisDiabetes Research and Clinical Practice, 2000
- Pharmacologic Therapy for Type 2 Diabetes MellitusAnnals of Internal Medicine, 1999
- Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers.European Journal of Clinical Pharmacology, 1999
- Outcome of Metformin-Facilitated Reinitiation of Oral Diabetic Therapy in Insulin-Treated Patients with Non-Insulin-Dependent Diabetes MellitusEndocrine Practice, 1997
- Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1995